Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-05-24
1998-05-26
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 2625, A61K 3170, C07H 19207
Patent
active
057564795
ABSTRACT:
The present invention provides an inhibitor of monoamine oxidase comprising a modified synthetic flavin adenine dinucleotide compound. Also provided is a method of inhibiting monoamine oxidase enzymatic activity in a cell, comprising the step of contacting said cell with a pharmacologically effective dose of a modified synthetic flavin adenine dinucleotide compound. Further provided is a method of treating a brain pathophysiological state in an individual, comprising administering a therapeutically effective dose of a modified synthetic flavin adenine dinucleotide compound to said individual.
REFERENCES:
Pinto et al., "Inhibition of Riboflavin Metabolism in Rat Tissues by Chloropromazine, Imipramine, and Amitriptyline," J. Clin. Invest., 67(4),1500-1506 (1981).
Weyler et al., "Catalytically Active Monoamine Oxidase Type A from Human Liver Expressed in Saccharomyces cerevisiae Contains Covalent FAD," Biochem. Biophys. Res. Comm., 173(3), 1205-1211 (1990).
Gomez et al., "A Comparative Study of Some Kinetic and Molecular Properties of Microsomal and Mitochondrial Monoamine Oxidase," Biochemical Pharmacology, 37(18), 3407-3413 (1988).
Barber et al., "Anti-Flavin Antibodies," Biochemical Journal, 242, 89-95 (1987).
T. W. Stone (I), "Adenine Dinucleotide Effects in the Nervous System," in Physiology and Pharmacology of Adenosine Derivatives, Daly et al. eds., Raven Press, New York, NY, 1983, pp. 237-244.
Tat'yanenko et al., Tyramine Oxidase Studied Using Structural Analogs of Flavine Adenine Dinucleotide, Mol. Biol. (Moscow), 8(6), 871-878 (1974); Chem. Abstr., 82(17), p.185, Abstr. No. 108082k (1975); only Abstract supplied.
McCormick et al., "Coenzyme Specificity of D-Amino Acid Oxidase for the Adenylate Moiety of FAD," Biochim. Biophys. Acta, 89, 4476-452 (1964).
Wierenga et al., "Prediction of the Occurrence of the ADP-binding .beta..alpha..beta.-fold in Protiens, Using an Amino Acid Sequence Fingerprint," J. Mol. Biol., 187, 101-107 (1986).
Abell et al., "Molecular and Functional Properties of the Monoamine Oxidases," Heterocycles, 39(2), 933-955 (1994).
T. W. Stone (II), "Actions of Adenine Dinucleotides on the Vas Deferens, Guinea-Pig Taenia Caeci and Bladder," European J. of Pharmacology, 75(2-3), 93-102 (1981).
Abell Creed W.
Kwan Sau-Wah
Lewis Duane A.
Mamiya Blain M.
Zhou Binhua
Adler Benjamin Aaron
Crane L. Eric
Kight John
Research Development Foundation
LandOfFree
Flavin adenine dinucleotide analogue inhibitors of monoamine oxi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Flavin adenine dinucleotide analogue inhibitors of monoamine oxi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flavin adenine dinucleotide analogue inhibitors of monoamine oxi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960201